Question

1.
A 26-year-old woman who has recently undergone a liver transplant is taking tacrolimus, mycophenolate, and prednisone. She informs her doctor that she and her partner are ready to begin trying for a baby. Her transplant function remains stable. What is the most appropriate advice regarding conception?

She can stop mycophenolate immediately and start trying to conceive

She should continue mycophenolate and stop only after becoming pregnant

She should stop mycophenolate, switch to a safer alternative, and wait at least 6 weeks before trying to conceive

She can stop mycophenolate and start trying to conceive in 90 days

Unsure

2.
A 28-year-old woman with lupus nephritis is prescribed mycophenolate mofetil (MMF) to prevent disease flares. She is sexually active but does not plan to become pregnant at this time. What is the most appropriate contraception plan for her while on MMF?

Use of birth control pills alone

Use of an intrauterine device (IUD) and condoms

Use of birth control pills and condoms

Use of hormonal contraception is necessary in females with a male partner who has had a vasectomy

Unsure

3.
A 32-year-old woman with a history of kidney transplant is prescribed mycophenolate mofetil (MMF). She visits her doctor after discovering she is pregnant at 10 weeks. The doctor discontinues MMF and switches her to azathioprine. The patient asks why her pregnancy needs to be reported to the Mycophenolate Pregnancy Registry. What is the most appropriate response?

Reporting the pregnancy is required

Reporting the pregnancy is important to track outcomes and improve understanding of mycophenolate's effects during pregnancy

Reporting the pregnancy ensures that the patient will receive compensation for any birth defects

Reporting the pregnancy is required only if there are already signs of birth defects

Unsure

4.
Which of the following is the most effective method of contraception for CD when used alone?

Birth control pill

Female diaphragm

Intrauterine device

Vaginal ring

Unsure

5.
Which statement most accurately describes the mechanism of action?

Inhibits inosine monophosphate dehydrogenase to inhibit pyrimidine synthesis

Induces inosine monophosphate dehydrogenase to inhibit purine synthesis

Inhibits inosine monophosphate dehydrogenase to inhibit purine synthesis

Induces inosine monophosphate dehydrogenase to inhibit pyrimidine synthesis

Unsure

6.
LP is a 27-year-old female s/p living donor kidney transplant who presents to the pharmacy for a refill of her mycophenolate mofetil (Cellcept). During counseling, she mentions she is considering pregnancy in the near future and has stopped all forms of birth control. Which of the following statements best describes the risks associated with mycophenolate exposure during pregnancy?

Mycophenolate exposure during pregnancy is associated with third-trimester pregnancy loss

Mycophenolate use during pregnancy can increase the risk of congenital malformations, especially cleft lip and palate abnormalities, as well as malformations to the external ear, such as microtia

Mycophenolate is only associated with minimal risk during pregnancy, and the benefits of preventing rejection outweigh any fetal risk

Mycophenolate use during pregnancy is strongly associated with gastroschisis, a defect in the abdominal wall causing intestines to protrude outside the body

Unsure

7.
Maria is a 32-year-old kidney transplant recipient who is prescribed mycophenolate. During her clinic visit, the pharmacist provides counseling on the teratogenic risks and the REMS program. Maria seems unsure about which precautions to take. The clinic uses EMR alerts and provides printed handouts. Which of the following is the most appropriate next step to ensure Maria understands the REMS requirements?

Document that counseling was provided

Ask Maria to repeat the key risks and precautions in her own words

Rely on the EMR alert to remind staff at her next visit

Give her an additional printed handout with the same information

Unsure

8.
A transplant clinic has noticed inconsistent mycophenolate REMS compliance across providers. Some patients report incomplete counseling, and documentation is variable. The clinic wants to improve provider adherence to REMS requirements. Which of the following strategies is most likely to improve REMS adherence and risk communication?

Provide standardized counseling templates and educational sessions for providers

Use EMR alerts and prompts to remind providers to counsel patients

Implement teach-back with patients to confirm understanding

Provide culturally appropriate printed and digital patient education materials

Unsure

9.
How confident are you in your ability to manage patients taking mycophenolate?

Not at all confident

Somewhat confident

Confident

Highly confident

Answer 1

1. She should stop mycophenolate, switch to a safer alternative, and wait at least 6 weeks before trying to conceive.
- Rationale: MMF is teratogenic; women should discontinue MMF and be on an alternative (eg, azathioprine) and wait the recommended washout (commonly ≥6 weeks) before conception.

2. Use of an intrauterine device (IUD) and condoms.
- Rationale: MMF requires highly effective contraception; an IUD is very effective and adding condoms provides additional protection/back‑up.

3. Reporting the pregnancy is important to track outcomes and improve understanding of mycophenolate's effects during pregnancy.
- Rationale: The registry collects pregnancy outcome data to better define risks and guide counseling; reporting is voluntary but strongly encouraged.

4. Intrauterine device.
- Rationale: IUDs are among the most effective contraceptive methods when used alone.

5. Inhibits inosine monophosphate dehydrogenase to inhibit purine synthesis.
- Rationale: MMF inhibits IMPDH, blocking de novo guanine (purine) nucleotide synthesis important for lymphocyte proliferation.

6. Mycophenolate use during pregnancy can increase the risk of congenital malformations, especially cleft lip and palate abnormalities, as well as malformations to the external ear, such as microtia.
- Rationale: MMF exposure is associated with increased spontaneous abortion and a characteristic pattern of birth defects (eg, clefting, ear and facial anomalies).

7. Ask Maria to repeat the key risks and precautions in her own words.
- Rationale: Teach‑back confirms patient understanding more reliably than documentation or passive materials alone.

8. Provide standardized counseling templates and educational sessions for providers.
- Rationale: Standardized tools plus provider training most directly improve consistent REMS counseling and documentation across a clinic (often combined with EMR prompts and teach‑back).

9. Confident.